News from decision resources A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

( EuronextParis:BND)

Jul 02, 2015, 09:30 ET
Decision Resources Group Logo.

Retinal Specialists Indicate Strong Desire for DME Therapies Which Induce Greater Vision Gains or are Administered Less Frequently Than Currently Approved Anti-VEGF Therapies

 Decision Resources Group finds that surveyed U.S. and European retinal specialists identify less frequent dosing as the highest unmet need in...

Jul 01, 2015, 09:39 ET
Decision Resources Group Logo.

Surveyed Rheumatologists Report That Otezla's Oral Administration is its Single Greatest Advantage Over Currently Available Treatment Options

Decision Resources Group finds that the three most frequently cited advantages of Otezla are its oral administration, alternative mechanism of...

Jun 25, 2015, 10:48 ET
Decision Resources Group Logo

Interventional Cardiology Device Markets in Europe, Japan, Latin America, and the U.S. each have Unique Characteristics that Contribute to Market Dynamics

 Decision Resources Group finds that interventional cardiology (IC) device market dynamics depend heavily on geography. The European market...

Jun 17, 2015, 09:30 ET
Decision Resources Group Logo.

Asia Pacific Laparoscopic Device Market Strongly Impacted by Economic Expansion, Domestic Manufacturing, and Varying Device Preferences

Decision Resources Group finds that the laparoscopic device market in the Asia Pacific region—including Australia, China, India, and South...

Jun 12, 2015, 09:30 ET
Decision Resources Group Logo.

Economic Headwinds and Increasing Government Oversight Create New Challenges for Competitors in the Latin American Medtech Market

Decision Resources Group finds that economic instability and fluctuating currencies have created numerous hurdles for medical device manufacturers...

Jun 04, 2015, 09:30 ET
Decision Resources Group Logo.

The Cancer Immunotherapy Market Will Capture Major-Market Sales of Over $13 Billion In 2023 and Will be Dominated by Immune Checkpoint Inhibitors

 Decision Resources Group finds that the cancer immunotherapy market will experience an impressive 29% annual growth over the forecast period...

May 14, 2015, 09:00 ET

Decision Resources Group Sets Course in Helping Leading Healthcare Companies Understand the Convergence of Healthcare Markets

Decision Resources Group (DRG), a subsidiary of Piramal Enterprises Ltd., announced today that it has acquired Healthcare Business Insights (HBI),...

Mar 26, 2015, 12:30 ET
Decision Resources Group Logo.

Decision Resources Group Joins Veeva OpenKey Partner Program

 Decision Resources Group (DRG) today announced that it has joined the Veeva OpenKey Partner Program. Veeva OpenKey is a bold new approach to...

Mar 02, 2015, 11:00 ET
Decision Resources Group Logo.

Decision Resources Group acquires Activate Networks

Decision Resources Group, a leading research and advisory company focused on high-value healthcare data, insights and analytics, announced today...

Jan 15, 2015, 10:00 ET
Decision Resources Group Logo

Diane Corrado Appointed President, Life Sciences Product Solutions, for Decision Resources Group

 Decision Resources Group (DRG) today announced the promotion of Diane Corrado to the position of President, Life Sciences Product...

Jan 14, 2015, 11:00 ET

Mark Luck Olson Appointed President, Global Consulting Services, for Decision Resources Group

Decision Resources Group (DRG), one of the world's leading firms focusing on healthcare insights, data and analytics, and services, today announced...

Dec 19, 2014, 16:15 ET

U.S. Contrast Agent and Radiopharmaceutical Market Will Grow Modestly Through 2023

Decision Resources Group finds that the market for contrast agents and radiopharmaceuticals in the United States will grow slightly through 2023....

Dec 19, 2014, 15:55 ET
Decision Resources Group Logo.

Latin American Dental Biomaterial Market Will Expand at a 12 Percent Annual Growth Rate Through 2023

Decision Resources Group finds that the Latin American dental biomaterial market will grow at a 12 percent compound annual growth rate through...

Dec 18, 2014, 15:30 ET

U.S. Laparoscopic Device Market Will Reach Over $4.3 Billion by 2023

 Decision Resources Group finds that the laparoscopic device market in the United States will increase to a value of over $4.3 billion by 2023....

Dec 18, 2014, 14:00 ET
Decision Resources Group Logo

Asia Pacific Dental Biomaterial Market Will Grow Strongly Through 2023

 Decision Resources Group finds that the Asia Pacific dental biomaterial market will grow moderately through 2023 as the aging population,...

Dec 17, 2014, 15:00 ET
Decision Resources Group Logo

Latin American Electrophysiology Mapping and Ablation Device Market Will Reach Nearly $90 Million by 2023

 Decision Resources Group finds that the Latin American electrophysiology (EP) mapping and ablation device market will grow moderately through...

Dec 17, 2014, 12:34 ET
Decision Resources Group Logo.

U.S. And European Markets for Craniomaxillofacial Devices Will Grow Through 2023 Despite Pricing Pressures

 Decision Resources Group finds that the market for craniomaxillofacial (CMF) devices in the United States and Europe will grow through 2023....

Dec 03, 2014, 13:00 ET
Decision Resources Group Logo.

PCSK9 and CETP Inhibitors Are Set to Transform the Dyslipidemia Market

Decision Resources Group finds that the novel proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors and cholesteryl ester transfer...

Dec 02, 2014, 11:00 ET
Logo

The Type 2 Diabetes Population will Continue to Expand in China, But Patient Access to Novel Non-Insulin Treatments is Sub-Optimal

Decision Resources Group finds that, for the treatment of type 2 diabetes in China, patient access to premium-priced agents is impeded as not...

Dec 01, 2014, 13:46 ET
Decision Resources Group Logo

Based on a Review of 1,000 CKD-ND Patients' Charts, Nephrologists Often Under- or Over-Estimate their Use of Key Renal Medications

 Decision Resources Group finds that, based on a review of 1,000 charts for chronic kidney disease non-dialysis (CKD-ND) patients, audited...